结合临床标志物可以预测NYHA IV心力衰竭中的死亡率
Yi-Jiao Men1, Yan-Ling Dong1, Yu Gong1
1Department of Emergency, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China.
Scientific reports
|August 6, 2025
概括
早期评估心力衰竭的预后至关重要. 生物标志物包括cystatin C,尿酸,bnp,rdw和前专辑蛋白可以帮助预测严重心力衰竭患者的死亡率.
科学领域:
- 心脏病学 心脏病学
- 生物标志物 生物标志物
- 预测指标的预测指标
背景情况:
- 早期评估心力衰竭 (HF) 预后对于患者的结果至关重要.
- 一些生物标志物,包括脑性尿素 (BNP),尿酸 (UA),前专辑蛋白 (PA),红细胞分布宽度 (RDW) 和cystatin C (Cys C),都与HF的发展有关.
研究的目的:
- 评估BNP,UA,PA,RDW和CysC的综合诊断效用,作为预测纽约心脏协会 (NYHA) 分类IV心力衰竭 (IV-HF) 患者死亡率的指标.
主要方法:
- 一组由193名NYHA IV-HF患者组成的队列接受了临床和心声学评估.
- 收集了患者数据,并在六个月的随访期间监测了生存状况.
主要成果:
- 在6个月内,观察到38.34%的患者的死亡率.
- 较高的年龄水平,疾病持续时间,Cys C,UA,BNP,RDW和心脏尺寸,以及较低的PA和左心室喷射率 (LVEF),与死亡率的增加有关.
- Cys C,UA,BNP和RDW独立预测死亡率,而PA显示出一种保护性关联.
结论:
- 生物标志物如Cys C,UA,BNP,RDW和PA是NYHAIV-HF患者死亡的重要独立风险因素.
- 临床因素 (年龄,疾病持续时间) 和生物标志物水平 (RDW,Cys C,UA,BNP,PA) 的组合可以作为有效的诊断指标来预测这种患者群体的死亡率.
更多相关视频
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
2.2K
04:20Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
Published on: October 1, 2019
5.9K
相关概念视频
01:30Heart Failure IV: Classification and Diagnostic Evaluation
33
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
33
01:26Heart Failure III: Clinical Manifestations
47
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
47
01:30Heart Failure VII: Nursing Interventions
139
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
139
01:17Pathophysiology of Heart Failure
1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
01:29Heart Failure II: Pathophysiology
41
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
41
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
214
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
214